Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 August, 2017 17:16 IST
ICRA upgrades outlook of Adani Ports to 'Stable'
Source: IRIS | 28 Feb, 2017, 08.52AM
Comments  |  Post Comment

ICRA has reaffirmed the long term rating on the Rs 100.20 billion bank facilities and Rs 53.34 billion (reduced from Rs 68.84 billion) Non Convertible Debenture Programme of Adani Ports and Special Economic Zone (APSEZL) at [ICRA]AA+ (pronounced ICRA double A plus). The outlook on the long term rating has been revised to 'Stable' from 'Negative'.
 
ICRA has withdrawn the [ICRA]AA+ rating assigned to the Rs 15.50 billion Non Convertible Debenture Programme of Adani Ports (Q,N,C,F)* and SEZ. ICRA has also reaffirmed the short term rating of [ICRA]A1+ (pronounced as ICRA A one plus) on the Rs 67 billion Commercial Paper programme/short term debt programme of APSEZL.

The revision in outlook reflects the anticipated strengthening of credit metrics on account of significant reduction in advances to related/unrelated parties as well as the healthy growth in overall cargo volumes supported by container and liquid cargo volumes which now form over 60% of the total cargo throughput.

The revision in outlook further takes into account the bond covenants restricting the company from entering into any related party transactions other than those undertaken for permitted business and as undertaken in the ordinary course of business as well as the management’s stated intent of winding down remaining related party loans & advances partly by March 2017 and entirely by December 2017.

Shares of the company declined Rs 0.7, or 0.24%, to settle at Rs 296.75. The total volume of shares settled was 202,987 at the BSE (Monday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Lupin launches generic Seroquel XR tablets in US - 23-Aug-2017 16:08
Reliance Capital offers ESOP's worth Rs 3 bn - 23-Aug-2017 15:03
Zydus Cadila gets USFDAs final approval for Ziprasidone HCl capsules - 23-Aug-2017 12:27
Glenmark Pharma gets nod for Triamcinolone Acetonide ointment - 23-Aug-2017 09:58
Cambridge Technology acquires new client in AI - 23-Aug-2017 09:55
Ramco Systems bags order from global top 5 aircraft manufacturer - 22-Aug-2017 14:38
Tata Power JV synchronizes 186 MW Georgia Hydro Project in record time - 22-Aug-2017 14:03
JMD Ventures' arm inks pact with Amazon - 22-Aug-2017 11:07
Zydus Cadilla gets USFDAs final nod for Pindolol tablets - 22-Aug-2017 10:58
Dr Reddy's to get up to USD 32.5 mn milestone payments for DFD-06 - 22-Aug-2017 10:33
Eros Int'l Media's promoter completes sale of 11.8 mn shares - 22-Aug-2017 10:22
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer